PRISMMEDI.BO
Get informed when a big investor buys or sells
+ FollowOvervalued by 57.4% based on the discounted cash flow analysis.
| Market cap | $459.84 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.53 |
| Beta | 0.59 |
| Outstanding Shares | 14,575,000 |
| P/E Ratio | -50.64 |
|---|---|
| PEG | 46.51 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Prism Medico & Pharmacy Ltd., an entity in its developmental stages, is primarily involved in the acquisition, distribution, and sale of agricultural goods. Its current portfolio includes cattle feed, various fertilizers (encompassing or...